Mayne Pharma Appoints New President
Mayne Pharma appoints Stefan Cross as president of its US division.
Mayne Pharma Group Limited
has named Stefan Cross as president of Mayne Pharma USA. Cross is responsible for leading all of Mayne Pharma’s existing business operations and overseeing the expansion of Mayne Pharma’s pharmaceutical products division. In addition, Cross will manage the continued growth of contract pharmaceutical services as provided by Mayne Pharma’s subsidiary, Metrics.
Previously, Cross served as Mayne Pharma’s vice-president of business and corporate development, and played a role in the global commercialization of the company’s SUBACAP anti-fungal product. He has been involved inintegrating Metrics with Mayne Pharma, and in executing the company’s business strategy in Australia and the US. Cross headed marketing efforts in the Asia Pacific region for Hospira and led Hospira’s commercial operations in China, Hong Kong, and Taiwan. Prior to that, Cross worked for six years with Mayne Pharma Limited in Europe and Australia, and eight years with F.H. Faulding & Co. Limited.
Cross succeeds Phil Hodges, who founded Metrics and currently serves on the board of directors of Mayne Pharma Group Limited.
Source:
Mayne Pharma Group Limited
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
